At least half of all patients with heart failure (HF) are affected by frailty, a syndrome that limits
an individual ability to recover from acute stressors. While frailty affects up to 90% of patients …

Although sarcopenia has been a serious public health concern worldwide in recent years, its
effective prevention and intervention measures are still lacking. The latest research has …

BACKGROUND: Metabolomics has become a valuable tool for identifying potential new
biomarkers and metabolic profiles. It has the potential to improve the diagnosis and …

Objective The study aims to understand the effects of dietary fiber on muscle quality
parameters and sarcopenia. Methods Study data were collected from the National Health …

Obesity is a predictor of the development of systolic and diastolic heart failure (HF), but once
established, patients with HF and obesity have better outcomes than their leaner …

Background Sarcopenia and hypoalbuminemia have been identified as independent
predictors of increased adverse outcomes, including mortality and readmissions, in …

Background Sarcopenia is frequently found in patients with heart failure with reduced
ejection fraction (HFrEF) and is associated with reduced exercise capacity, poor quality of …

Adopting uniform diagnostic criteria for SO will enable more accurate characterization of
prevalence and cardiometabolic risk moving forward. Although current management …

Natriuretic peptides (NPs), including B-type natriuretic peptide (BNP) and N-terminal pro-
BNP (NT-proBNP), have been recommended as standard biomarkers for diagnosing heart …

Background Skeletal muscle wasting is critical in patients with heart failure (HF). Whereas
prior studies have employed appendicular lean mass (ALM) normalized by height squared …